Sphera Funds Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
|
|||||
|
2025
Q1 | $9.68M | Buy |
|
|||||
|
2024
Q4 | $9.62M | Buy |
|
|||||
|
2024
Q3 | $10.9M | Sell |
|
|||||
|
2024
Q2 | $12.1M | Buy |
|
|||||
|
2024
Q1 | $11.1M | Buy |
|
|||||
|
2023
Q4 | $9.61M | Sell |
|
|||||
|
2023
Q3 | $9.24M | Buy |
|
|||||
|
2023
Q2 | $8.47M | Hold |
|
|||||
|
2023
Q1 | $7.37M | Hold |
|
|||||
|
2022
Q4 | $8.51M | Buy |
|
|||||
|
2022
Q3 | $7.19M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.91M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $5.14M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $2.96M | Sell |
|
|||||
|
2015
Q2 | $4.88M | Buy |
|